Cash allocation. No separate rationale was supplied.

I expect JPM to provide a durable value-oriented financial allocation over coming quarters because its 14.58 P/E is supported by TTM diluted EPS of 23.95 and it pays a 1.72% trailing yield. I am wrong if subsequent results no longer support that earnings base; I exit if valuation discipline deteriorates.

Recorded Sep 18, 2026, 8:52 AM EDT · Conviction: high · Horizon: quarters

I expect AMGN to provide health-care income with a reasonable earnings valuation because it has TTM diluted EPS of 16.29, a 23.31 P/E, and a 2.62% trailing dividend yield. The 20-session return was negative 14.15%, warranting no larger weight. I am wrong if earnings weaken; I exit if valuation support erodes.

Recorded Sep 18, 2026, 8:52 AM EDT · Conviction: medium · Horizon: months

I expect PEP to support total return through income and reasonable valuation because its 4.34% trailing dividend yield is the highest in this book while its P/E is 19.95 on TTM diluted EPS of 6.70. I am wrong if earnings weaken materially; I exit if that income-and-valuation balance erodes.

Recorded Sep 18, 2026, 8:52 AM EDT · Conviction: high · Horizon: quarters

I expect PG to provide balanced defensive income because it trades at a 21.38 P/E, has TTM diluted EPS of 6.90, and offers a 2.91% trailing dividend yield. I am wrong if earnings durability declines; I exit if future filings no longer support this valuation and income balance.

Recorded Sep 18, 2026, 8:52 AM EDT · Conviction: high · Horizon: quarters

I expect QCOM to remain a value-supported technology holding because it reports TTM diluted EPS of 13.96 at a 13.52 P/E and a 1.92% trailing dividend yield. I am wrong if the reported margin compression and handset-revenue pressure persist beyond several quarters; I exit if earnings no longer sustain valuation support.

Recorded Sep 18, 2026, 8:52 AM EDT · Conviction: medium · Horizon: months

I expect WFC to contribute steady financial exposure because it has the lowest supplied P/E among the bank holdings at 12.67, earned TTM diluted EPS of 6.86, and carries a 2.13% trailing dividend yield. I am wrong if earnings weaken materially; I exit if the valuation advantage is no longer supported.

Recorded Sep 18, 2026, 8:52 AM EDT · Conviction: high · Horizon: quarters

I expect AXP to add consumer-finance diversification with measured valuation support because TTM diluted EPS is 17.03, the P/E is 18.27, and the trailing dividend yield is 1.14%. I am wrong if future filings weaken the earnings base; I exit if the valuation ceases to justify a dedicated allocation.

Recorded Sep 18, 2026, 8:52 AM EDT · Conviction: medium · Horizon: quarters

I expect GS to add a modest earnings-and-income financial sleeve because its TTM diluted EPS is 61.69, its P/E is 15.42, and its trailing dividend yield is 1.89%. I am wrong if earnings durability fails to persist; I exit if updated results invalidate the present valuation support.

Recorded Sep 18, 2026, 8:52 AM EDT · Conviction: medium · Horizon: months

I expect HD to contribute income and consumer-discretionary diversification because its TTM diluted EPS is 16.29, P/E is 18.57, and trailing dividend yield is 3.07%. Its 20-session return was negative 12.14%, so position size remains measured. I am wrong if earnings weaken; I exit if valuation support fades.

Recorded Sep 18, 2026, 8:52 AM EDT · Conviction: medium · Horizon: months

I expect JNJ to preserve diversified health-care exposure because it has TTM diluted EPS of 8.82 and a 1.95% trailing dividend yield. The 30.64 P/E and neutral supplied assessment justify a moderate, not dominant, allocation. I am wrong if earnings expectations weaken; I exit if valuation remains unsupported.

Recorded Sep 18, 2026, 8:52 AM EDT · Conviction: medium · Horizon: quarters

I expect MA to provide a measured payment-processing allocation because it reports TTM diluted EPS of 17.73 and has a 0.60% trailing dividend yield. Its 31.91 P/E calls for a moderate weight rather than concentration. I am wrong if earnings durability weakens; I exit if subsequent results do not justify the valuation.

Recorded Sep 18, 2026, 8:52 AM EDT · Conviction: medium · Horizon: quarters

I expect COP to provide a diversified energy allocation with balanced valuation and income because its TTM diluted EPS is 7.95, P/E is 16.75, and trailing dividend yield is 2.52%. Its 20-session return was 2.00%, not a basis for an oversized position. I am wrong if earnings weaken; I exit if valuation support is lost.

Recorded Sep 18, 2026, 8:52 AM EDT · Conviction: medium · Horizon: months

I expect CRM to add measured software earnings exposure because it reports TTM diluted EPS of 10.86 at a 22.36 P/E. Its 20-session return was 17.84%, so the allocation remains moderate rather than momentum-led. I am wrong if earnings durability does not continue; I exit if subsequent results fail to support the current valuation.

Recorded Sep 18, 2026, 8:52 AM EDT · Conviction: medium · Horizon: months

I expect KO to furnish a measured staples allocation because it has a 2.38% trailing dividend yield and TTM diluted EPS of 3.42 at a 25.75 P/E. Recent supplied commentary notes 7% sales growth and an 11% EPS increase. I am wrong if those earnings trends reverse; I exit if valuation expands without support.

Recorded Sep 18, 2026, 8:52 AM EDT · Conviction: medium · Horizon: quarters

I expect TMO to retain a small life-sciences allocation because it earned TTM diluted EPS of 17.66 and recently announced a genomics, proteomics, and biobanking partnership. Its 37.28 P/E requires restraint despite a 7.30% 20-session return. I am wrong if earnings fail to justify that valuation; I exit if it persists.

Recorded Sep 18, 2026, 8:52 AM EDT · Conviction: medium · Horizon: months